Dow Down 0.25% Nasdaq Down 0.26%

Xenoport, Inc. (XNPT)

-NasdaqGS
4.89 Down 0.28(5.42%) 4:00PM EDT
Prev Close:5.17
Open:5.12
Bid:4.00 x 1000
Ask:5.00 x 2000
1y Target Est:7.67
Beta:0.9
Earnings Date:Nov 5 - Nov 10 (Est.)
Day's Range:4.88 - 5.20
52wk Range:3.15 - 7.20
Volume:249,639
Avg Vol (3m):308,032
Market Cap:304.21M
P/E (ttm):N/A
EPS (ttm):-1.66
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
XNPTDown 5.42%304.21M
ABTDown 0.59%63.68B
AZNUp 0.94%93.77B
PFEDown 0.37%186.29B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):22.79
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.42
Quarterly EPS Est (Sep-14) :-0.36
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):-0.68

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

XenoPort, Inc., a biopharmaceutical company, focuses on developing and commercializing a portfolio of internally discovered product candidates for the treatment of neurological and other disorders. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback